Montréal-based healthtech company Optina Diagnostics has raised $24 million CAD in its Series A round to support the FDA regulatory submission of its early-detection disease solution.
seen from Malaysia

seen from Czechia
seen from India

seen from United Kingdom
seen from China
seen from China
seen from Türkiye

seen from Spain

seen from Greece
seen from Canada
seen from Greece
seen from Saudi Arabia

seen from Australia
seen from Saudi Arabia
seen from Canada
seen from Switzerland

seen from Romania

seen from China
seen from Argentina
seen from China
Montréal-based healthtech company Optina Diagnostics has raised $24 million CAD in its Series A round to support the FDA regulatory submission of its early-detection disease solution.